巨多糖缺失增强载脂蛋白e缺乏小鼠凝血酶生成:对炎症和动脉粥样硬化的影响。

M. Grandoch, Christina Kohlmorgen, A. Melchior-Becker, Kathrin Feldmann, S. Homann, Julia Müller, L. Kiene, Jinyang Zeng-Brouwers, Friederike Schmitz, N. Nagy, A. Polzin, N. Gowert, M. Elvers, P. Skroblin, X. Yin, M. Mayr, L. Schaefer, Lisa R Tannock, J. Fischer
{"title":"巨多糖缺失增强载脂蛋白e缺乏小鼠凝血酶生成:对炎症和动脉粥样硬化的影响。","authors":"M. Grandoch, Christina Kohlmorgen, A. Melchior-Becker, Kathrin Feldmann, S. Homann, Julia Müller, L. Kiene, Jinyang Zeng-Brouwers, Friederike Schmitz, N. Nagy, A. Polzin, N. Gowert, M. Elvers, P. Skroblin, X. Yin, M. Mayr, L. Schaefer, Lisa R Tannock, J. Fischer","doi":"10.1161/ATVBAHA.115.306973","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\nThrombin signaling promotes atherosclerosis by initiating inflammatory events indirectly through platelet activation and directly via protease-activated receptors. Therefore, endogenous thrombin inhibitors may be relevant modulators of atheroprogression and cardiovascular risk. In addition, endogenous thrombin inhibitors may affect the response to non-vitamin K-dependent oral anticoagulants. Here, the question was addressed whether the small leucine-rich proteoglycan biglycan acts as an endogenous thrombin inhibitor in atherosclerosis through activation of heparin cofactor II.\n\n\nAPPROACH AND RESULTS\nBiglycan concentrations were elevated in the plasma of patients with acute coronary syndrome and in male Apolipoprotein E-deficient (ApoE(-/-)) mice. Biglycan was detected in the glycocalyx of capillaries and the subendothelial matrix of arterioles of ApoE(-/-) mice and in atherosclerotic plaques. Thereby a vascular compartment is provided that may mediate the endothelial and subendothelial activation of heparin cofactor II through biglycan. ApoE and Bgn double-deficient (ApoE(-/-)/Bgn(-/0)) mice showed higher activity of circulating thrombin, increased platelet activation and platelet adhesion in vivo, supporting a role of biglycan in balancing thrombin activity. Furthermore, concentrations of circulating cytokines and aortic macrophage content were elevated in ApoE(-/-)/Bgn(-/0) mice, suggesting a proinflammatory phenotype. Elevated platelet activation and macrophage accumulation were reversed by treating ApoE(-/-)/Bgn(-/0) mice with the thrombin inhibitor argatroban. Ultimately, ApoE(-/-)/Bgn(-/0) mice developed aggravated atherosclerosis.\n\n\nCONCLUSIONS\nThe present results indicate that biglycan plays a previously unappreciated protective role during the progression of atherosclerosis by inhibiting thrombin activity, platelet activation, and finally macrophage-mediated plaque inflammation.","PeriodicalId":8404,"journal":{"name":"Arteriosclerosis, Thrombosis, & Vascular Biology","volume":"68 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"34","resultStr":"{\"title\":\"Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis.\",\"authors\":\"M. Grandoch, Christina Kohlmorgen, A. Melchior-Becker, Kathrin Feldmann, S. Homann, Julia Müller, L. Kiene, Jinyang Zeng-Brouwers, Friederike Schmitz, N. Nagy, A. Polzin, N. Gowert, M. Elvers, P. Skroblin, X. Yin, M. Mayr, L. Schaefer, Lisa R Tannock, J. Fischer\",\"doi\":\"10.1161/ATVBAHA.115.306973\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE\\nThrombin signaling promotes atherosclerosis by initiating inflammatory events indirectly through platelet activation and directly via protease-activated receptors. Therefore, endogenous thrombin inhibitors may be relevant modulators of atheroprogression and cardiovascular risk. In addition, endogenous thrombin inhibitors may affect the response to non-vitamin K-dependent oral anticoagulants. Here, the question was addressed whether the small leucine-rich proteoglycan biglycan acts as an endogenous thrombin inhibitor in atherosclerosis through activation of heparin cofactor II.\\n\\n\\nAPPROACH AND RESULTS\\nBiglycan concentrations were elevated in the plasma of patients with acute coronary syndrome and in male Apolipoprotein E-deficient (ApoE(-/-)) mice. Biglycan was detected in the glycocalyx of capillaries and the subendothelial matrix of arterioles of ApoE(-/-) mice and in atherosclerotic plaques. Thereby a vascular compartment is provided that may mediate the endothelial and subendothelial activation of heparin cofactor II through biglycan. ApoE and Bgn double-deficient (ApoE(-/-)/Bgn(-/0)) mice showed higher activity of circulating thrombin, increased platelet activation and platelet adhesion in vivo, supporting a role of biglycan in balancing thrombin activity. Furthermore, concentrations of circulating cytokines and aortic macrophage content were elevated in ApoE(-/-)/Bgn(-/0) mice, suggesting a proinflammatory phenotype. Elevated platelet activation and macrophage accumulation were reversed by treating ApoE(-/-)/Bgn(-/0) mice with the thrombin inhibitor argatroban. Ultimately, ApoE(-/-)/Bgn(-/0) mice developed aggravated atherosclerosis.\\n\\n\\nCONCLUSIONS\\nThe present results indicate that biglycan plays a previously unappreciated protective role during the progression of atherosclerosis by inhibiting thrombin activity, platelet activation, and finally macrophage-mediated plaque inflammation.\",\"PeriodicalId\":8404,\"journal\":{\"name\":\"Arteriosclerosis, Thrombosis, & Vascular Biology\",\"volume\":\"68 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"34\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arteriosclerosis, Thrombosis, & Vascular Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1161/ATVBAHA.115.306973\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, & Vascular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.115.306973","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 34

摘要

目的:凝血酶信号通过间接激活血小板和直接通过蛋白酶激活受体引发炎症事件,促进动脉粥样硬化。因此,内源性凝血酶抑制剂可能是动脉粥样硬化进展和心血管风险的相关调节剂。此外,内源性凝血酶抑制剂可能影响对非维生素k依赖性口服抗凝剂的反应。本文探讨了富含亮氨酸的小蛋白多糖biglycan是否通过激活肝素辅助因子II在动脉粥样硬化中发挥内源性凝血酶抑制剂的作用。方法和结果急性冠脉综合征患者和载脂蛋白e缺乏(-/-)雄性小鼠血浆中多糖浓度升高。在ApoE(-/-)小鼠毛细血管糖萼和小动脉内皮下基质以及动脉粥样硬化斑块中检测到Biglycan。因此,提供了一种血管腔室,可以通过大聚糖介导肝素辅助因子II的内皮和亚内皮活化。ApoE和Bgn双缺陷(ApoE(-/-)/Bgn(-/0))小鼠体内循环凝血酶活性升高,血小板活化和血小板粘附增加,支持高聚糖在平衡凝血酶活性中的作用。此外,ApoE(-/-)/Bgn(-/0)小鼠的循环细胞因子浓度和主动脉巨噬细胞含量升高,提示促炎表型。用凝血酶抑制剂阿加曲班治疗ApoE(-/-)/Bgn(-/0)小鼠,可逆转血小板活化升高和巨噬细胞积聚。最终,ApoE(-/-)/Bgn(-/0)小鼠出现了加重的动脉粥样硬化。结论目前的研究结果表明,多糖在动脉粥样硬化的进展过程中发挥了一种以前未被认识到的保护作用,它通过抑制凝血酶活性、血小板活化,并最终抑制巨噬细胞介导的斑块炎症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis.
OBJECTIVE Thrombin signaling promotes atherosclerosis by initiating inflammatory events indirectly through platelet activation and directly via protease-activated receptors. Therefore, endogenous thrombin inhibitors may be relevant modulators of atheroprogression and cardiovascular risk. In addition, endogenous thrombin inhibitors may affect the response to non-vitamin K-dependent oral anticoagulants. Here, the question was addressed whether the small leucine-rich proteoglycan biglycan acts as an endogenous thrombin inhibitor in atherosclerosis through activation of heparin cofactor II. APPROACH AND RESULTS Biglycan concentrations were elevated in the plasma of patients with acute coronary syndrome and in male Apolipoprotein E-deficient (ApoE(-/-)) mice. Biglycan was detected in the glycocalyx of capillaries and the subendothelial matrix of arterioles of ApoE(-/-) mice and in atherosclerotic plaques. Thereby a vascular compartment is provided that may mediate the endothelial and subendothelial activation of heparin cofactor II through biglycan. ApoE and Bgn double-deficient (ApoE(-/-)/Bgn(-/0)) mice showed higher activity of circulating thrombin, increased platelet activation and platelet adhesion in vivo, supporting a role of biglycan in balancing thrombin activity. Furthermore, concentrations of circulating cytokines and aortic macrophage content were elevated in ApoE(-/-)/Bgn(-/0) mice, suggesting a proinflammatory phenotype. Elevated platelet activation and macrophage accumulation were reversed by treating ApoE(-/-)/Bgn(-/0) mice with the thrombin inhibitor argatroban. Ultimately, ApoE(-/-)/Bgn(-/0) mice developed aggravated atherosclerosis. CONCLUSIONS The present results indicate that biglycan plays a previously unappreciated protective role during the progression of atherosclerosis by inhibiting thrombin activity, platelet activation, and finally macrophage-mediated plaque inflammation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Editors and Editorial Board. Correction to: Role of LpL (Lipoprotein Lipase) in Macrophage Polarization In Vitro and In Vivo. Tribute to Paul M. Vanhoutte, MD, PhD (1940-2019). Correction to: 18F-Sodium Fluoride Imaging of Coronary Atherosclerosis in Ambulatory Patients With Diabetes Mellitus. Extracellular MicroRNA-92a Mediates Endothelial Cell-Macrophage Communication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1